Hemoglobin A1c in youth and adults with cystic fibrosis related diabetes decreases after elexacaftor-tezacaftor-ivacaftor
- 14 March 2025
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 755-758
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Research Institute
- Cystic Fibrosis Foundation (ZEMANI20Y7)
- Cystic Fibrosis Foundation (LORENZ22H0)
- Cystic Fibrosis Foundation (MORAN19GE3)
- Cystic Fibrosis Foundation (WOOD19GE0)
This publication has 12 references indexed in Scilit:
- Effect of 18 months elexacaftor-tezacaftor-ivacaftor on body mass index and glycemic control in adults with cystic fibrosisClinical Nutrition ESPEN, 2023
- Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetesDiabetes & Metabolism, 2023
- Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator TherapyThe Journal of Clinical Endocrinology & Metabolism, 2023
- Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/IvacaftorHormone Research in Paediatrics, 2023
- Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosisJournal of Cystic Fibrosis, 2023
- Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysisMetabolism, 2022
- Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipientsJournal of Cystic Fibrosis, 2022
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del AlleleNew England Journal of Medicine, 2019
- Diabetes-related Mortality in Adults with Cystic Fibrosis. Role of Genotype and SexAmerican Journal of Respiratory and Critical Care Medicine, 2015
- The long and winding road to optimal HbA1c measurementClinica Chimica Acta, 2013